摘要呼吸道合胞病毒（RSV）是引起儿童呼吸道感染的重要病原之一，也是造成儿童住院及死亡的主要原因。但目前治疗措施以支持治疗为主，缺乏特异性抗病毒药物，预防RSV感染非常重要。主动、被动免疫为预防感染的主要方式，但由于单克隆抗体价格昂贵及部分需多剂注射 ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

RSV vaccine access expanded to some people in their 50s, according to CDC website. The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...